GCWM
APGN

Graham Capital Wealth Management’s Apexigen, Inc. Common Stock APGN Stock Holding History

Graham Capital Wealth Management’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,945
Closed -$110K – 116
2022
Q1 		$110K Buy
+10,945
New +$110K 0.1% 99

Other funds holding APGN

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

Graham Capital Wealth Management's APGN Position: Q2 2022 in Review

Graham Capital Wealth Management sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2022, closing a stake of 10,945 shares — an estimated $110K sold.

Graham Capital Wealth Management first reported a position in APGN in Q1 2022 and held it in 1 quarter. The position peaked at $110K in Q1 2022. 27 funds tracked by Wall St. Rank hold APGN as of Q2 2022.

  • Graham Capital Wealth Management reported no remaining Apexigen, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Graham Capital Wealth Management sold 10,945 Apexigen, Inc. Common Stock shares in Q2 2022, an estimated $110K.
  • Graham Capital Wealth Management first reported a position in Apexigen, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Graham Capital Wealth Management's Apexigen, Inc. Common Stock position peaked at $110K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2022.

Based on Graham Capital Wealth Management's 13F filing for Q2 2022, filed 9 Aug 2022.